FDA Approves First Therapy for Menkes Disease
FDA Approves First Therapy for Menkes Disease General Studies Paper II: Health Why in News? The U.S. Food and Drug Administration (FDA) has approved Zycubo (copper histidinate) as the first and only therapy for Menkes disease. This subcutaneous treatment significantly improves survival in affected infants by delivering usable copper, offering new hope for children who […]
FDA Approves First Therapy for Menkes Disease Read More »










